<i>Lactobacillus crispatus</i> BC1 Biosurfactant Counteracts the Infectivity of <i>Chlamydia trachomatis</i> Elementary Bodies
Lactobacilli-derived biosurfactants (BS) have shown promising effects as antimicrobial molecules. Since <i>Lactobacillus crispatus</i> plays a crucial role in maintaining vaginal eubiosis, BS from this species could represent novel therapeutic agents to counteract sexually transmitted pa...
Main Authors: | Claudio Foschi, Carola Parolin, Barbara Giordani, Sara Morselli, Barbara Luppi, Beatrice Vitali, Antonella Marangoni |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Microorganisms |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-2607/9/5/975 |
Similar Items
-
Anti-<i>Candida</i> Activity of Hyaluronic Acid Combined with <i>Lactobacillus</i> <i>crispatus</i> Lyophilised Supernatant: A New Antifungal Strategy
by: Carola Parolin, et al.
Published: (2021-05-01) -
<i>Lactobacillus crispatus</i> BC1 Biosurfactant Delivered by Hyalurosomes: An Advanced Strategy to Counteract <i>Candida</i> Biofilm
by: Angela Abruzzo, et al.
Published: (2021-01-01) -
Lactobacillus crispatus BC5 Interferes With Chlamydia trachomatis Infectivity Through Integrin Modulation in Cervical Cells
by: Carola Parolin, et al.
Published: (2018-11-01) -
Prevalence of <i>Chlamydia trachomatis</i> Infection, Serovar Distribution and Co-Infections with Seven High-Risk HPV Types among Italian Women with a Recent History of Abnormal Cervical Cytology
by: Marianna Martinelli, et al.
Published: (2019-09-01) -
Biosurfactant from vaginal Lactobacillus crispatus BC1 as a promising agent to interfere with Candida adhesion
by: Priscilla Romina De Gregorio, et al.
Published: (2020-06-01)